Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.
about
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s DiseaseParkinson's Disease and Cognitive ImpairmentDemography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem).Comparative cardiovascular safety of dementia medications: a cross-national study.The spectrum of cognitive impairment in Lewy body diseasesDiscovery of 3-Arylcoumarin-tetracyclic Tacrine Hybrids as Multifunctional Agents against Parkinson's DiseaseNon-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space.Clinical approach to Parkinson's disease: features, diagnosis, and principles of management.Cholinergic and perfusion brain networks in Parkinson disease dementia.Neurobiology of cognitive impairment in Parkinson's disease.The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies.Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease.Cholinergic deficit and response to donepezil therapy in Parkinson's disease with dementia.Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.Pimavanserin: novel pharmacotherapy for Parkinson's disease psychosis.Neuroprotective Effects and Mechanisms of Action of Multifunctional Agents Targeting Free Radicals, Monoamine Oxidase B and Cholinesterase in Parkinson's Disease Model.
P2860
Q24188194-9E57C9F1-349E-4331-BD72-CE36454D2603Q30239814-0B99A2AF-CCCF-481B-A060-C8A1D0F9EB38Q30654813-5501CE9F-BFF7-4687-8690-F6EF4505AC7DQ33162060-A1DF2E2F-8CD7-4174-BB59-4C7321880DCDQ34019751-778D8B6B-B9AE-44A5-9D55-F5DF377C5709Q34310215-7AB7A7D8-8B7C-4647-8397-EAF22013AC0BQ35625767-DFA214B4-BA40-4F5E-AD70-8BE3401A5F1FQ36009241-5C8B680A-05F7-4504-B700-E05E25C4AF0BQ37082956-D005A8E7-A956-4980-9454-579BFC3ACBC8Q38067143-62C3E9C1-E129-4D1C-BA23-E3AD3D0F2F75Q38083586-75188234-2CBD-4DF2-B6FD-F3F3225B09F0Q38225930-2D764514-F390-4793-B294-582E2D315D16Q38258699-6175996B-AA23-46D7-B265-A78E7F097D54Q38661735-957AAE2D-0CE6-4771-8915-8560912F38CEQ45341017-EF9497E2-531A-4C70-90B1-2C347DE46572Q47178205-31CB1BFD-EF3E-478D-9B52-9A4B41641663Q48428964-B10D294D-328C-47B9-BF9A-060E2BE95DACQ48642615-741E9189-472A-430D-93F2-8F19A2A8AAB5Q50092339-623427D4-5ACA-4EC9-8D3D-3DA20898CE67Q52734704-4CE50715-7854-4CA1-94DB-0CB08346B1C0
P2860
Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@ast
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@en
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@nl
type
label
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@ast
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@en
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@nl
prefLabel
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@ast
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@en
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@nl
P2093
P2860
P1476
Effects of cholinesterase inhi ...... ia: a review of clinical data.
@en
P2093
James E Galvin
Paolo Barone
Peter Paul De Deyn
P2860
P304
P356
10.1111/J.1755-5949.2010.00166.X
P577
2010-07-07T00:00:00Z